Synthesis of Selenazolopyridine Derivatives with Capability to Induce Apoptosis in Human Breast Carcinoma MCF-7 Cells Through Scavenge of Intracellular ROS.

Meiyun Zhou,Shengbin Ji,Zhaojun Wu,Yiqun Li,Wenjie Zheng,Hua Zhou,Tianfeng Chen
DOI: https://doi.org/10.1016/j.ejmech.2015.03.069
IF: 7.088
2015-01-01
European Journal of Medicinal Chemistry
Abstract:A series of selenazolopyridine derivatives have been synthesized and characterized by X-ray diffraction, high resolution NMR and Mass spectrum. The in vitro anticancer activities of the synthetic compounds were screened against a panel of human cancer cell lines, human breast carcinoma MCF-7 cells, human liver carcinoma HepG2 cells and L02 normal cell line by MTT assay. By analyzing the structure-activity relationship among the synthetic compounds, it was found that 2-(phenylamino) selenazolo [5,4-b] pyridine, (PSeD, 7) had higher growth inhibitory effect on MCF-7 cells. The intracellular mechanism of cell death was evaluated by flow cytometric analysis and ROS assay, which revealed that PSeD could induce MCF-7 cells apoptosis by scavenging intracellular ROS. Taken together, we regard PSeD as an antioxidant which could inhibit cancer cell growth through induction of apoptosis.
What problem does this paper attempt to address?